A carregar...
In Vitro Antimycobacterial Spectrum of a Diarylquinoline ATP Synthase Inhibitor
The diarylquinoline R207910 is in clinical development for tuberculosis treatment. The MIC(50) for 41 drug-susceptible and 44 multidrug-resistant Mycobacterium tuberculosis clinical isolates was 0.032 μg/ml. Out of 20 additional mycobacterial species, three were found to be naturally resistant to R2...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Microbiology (ASM)
2007
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2151410/ https://ncbi.nlm.nih.gov/pubmed/17709466 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00181-07 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|